John S Patton

Summary

Affiliation: Nektar Therapeutics
Country: USA

Publications

  1. ncbi request reprint Inhaling medicines: delivering drugs to the body through the lungs
    John S Patton
    Nektar Therapeutics, 150 Industrial Road, San Carlos, California 94070, USA
    Nat Rev Drug Discov 6:67-74. 2007
  2. ncbi request reprint Clinical pharmacokinetics and pharmacodynamics of inhaled insulin
    John S Patton
    Nektar Therapeutics, San Carlos, California 94070, USA
    Clin Pharmacokinet 43:781-801. 2004
  3. ncbi request reprint A historical perspective on convergence technology
    John S Patton
    Nektar Therapeutics
    Nat Biotechnol 24:280-1. 2006
  4. ncbi request reprint The lungs as a portal of entry for systemic drug delivery
    John S Patton
    Nektar Therapeutics, Research Department, 150 Industrial Road, San Carlos, CA 94070, USA
    Proc Am Thorac Soc 1:338-44. 2004
  5. ncbi request reprint Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung
    John S Patton
    Nektar Therapeutics, 150 Industrial Road, San Carlos, CA 94070, USA
    Diabetes Obes Metab 7:S5-8. 2005

Detail Information

Publications5

  1. ncbi request reprint Inhaling medicines: delivering drugs to the body through the lungs
    John S Patton
    Nektar Therapeutics, 150 Industrial Road, San Carlos, California 94070, USA
    Nat Rev Drug Discov 6:67-74. 2007
    ..Here, we review these advances, and discuss aspects of lung physiology and formulation composition that influence the systemic delivery of inhaled therapeutics...
  2. ncbi request reprint Clinical pharmacokinetics and pharmacodynamics of inhaled insulin
    John S Patton
    Nektar Therapeutics, San Carlos, California 94070, USA
    Clin Pharmacokinet 43:781-801. 2004
    ..Clinical experience to date indicates that inhaled insulin has the potential to be an effective treatment in patients with diabetes, and that it may have particular utility in the treatment of postprandial hyperglycaemia...
  3. ncbi request reprint A historical perspective on convergence technology
    John S Patton
    Nektar Therapeutics
    Nat Biotechnol 24:280-1. 2006
  4. ncbi request reprint The lungs as a portal of entry for systemic drug delivery
    John S Patton
    Nektar Therapeutics, Research Department, 150 Industrial Road, San Carlos, CA 94070, USA
    Proc Am Thorac Soc 1:338-44. 2004
    ..Small molecules can exhibit prolonged absorption if they are highly insoluble or highly cationic. Encapsulation in slow release particles such as liposomes can also be used to control absorption...
  5. ncbi request reprint Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung
    John S Patton
    Nektar Therapeutics, 150 Industrial Road, San Carlos, CA 94070, USA
    Diabetes Obes Metab 7:S5-8. 2005
    ..Delivering aerosolized drugs via the lungs avoids the necessity for SC injections and thereby may increase the patient's acceptability of an insulin-based therapeutic regimen...